Abstract
The ability of rat lung to remove the local anaesthetic drug bupivacaine from the blood was studied in isolated organs which were perfused either in an open (single-pass mode) or in a closed system (recirculating medium).
Isolated perfused rat lungs exhibited a very low capacity to metabolize bupivacaine within 3 h during which the drug circulated continuously through the organ. The clearance values differed only by 0.2 ml/min from the control parameters in sham perfusions. The calculated extraction ratio was 0.2% and the elimination half-life was about 210 min. The volume of distribution of bupivacaine was 133 ml which remarkably surmounted the reference values obtained for sham perfusions.
The distribution of bupivacaine into the pulmonary tissue was investigated applying the multiple indicator dilution technique to isolated lungs perfused in the single-pass mode. The mean elimination time of model compounds for distribution into the intravascular space, 14C-inulin, and the total water space, 3H-water, were 68 and 75 s at a flow rate of 6 ml/min. The volume of distribution was 5.9 ml for inulin and 6.5 ml for water. The mean transit time for concomitantly injected bupivacaine was 221 s and the volume of distribution was 14.4 ml. The respective parameters of sham perfusions performed without an isolated organ were substantially lower, i.e. mean elimination time 50, 50 and 61 s and distribution volume 4.9, 5.0 and 6.1 ml for inulin, water and bupivacaine.
The volume of distribution during single-pass contact of bupivacaine to lung was not substantially influenced by an increase of the flow rate from 6 to 9 and 12 ml/min whereas the mean transit time dropped from 221 to 121 and 108 s, respectively. These results support the assumption that bupivacaine is extensively retained by the pulmonary tissue and that elimination of bupivacaine by metabolism can be neglegted for lung.
The hemodynamic parameters of bronchiolar perfusion in the artificially perfused lung were determined using two fluorochrome-labeled macromolecular proteins, i.e. fluorescein-isothiocyanate (FITC)- and lissamine-rhodamine-B 200 (RB 200)-labeled globulin. After 10 min of perfusion at a flow rate of 12 ml/min in the closed system an area of 10.8070 of the peribronchiolar tissue area contained the dye-label FITC. A very similar index (10.1%) of dye-coloured capillaries was obtained when the lungs of anaesthetized rats were examined 10 min after intravenous injection of the fluorochrome into the pulmonary artery in vivo. In isolated perfused rat lungs receiving both FITC and RB 200 59.5% of FITC-labeled capillaries were reached by the second fluorochrome within 2 s. This fraction accounted for 93.3% after 10 s of circulation time. This proves that isolated rat lungs were well perfused in vitro.
Similar content being viewed by others
References
Arthur GR (1987) Pharmacokinetics of local anesthetics. In: Strichartz GR (ed) Local anesthetics. Handbook of experimental pharmacology, vol 81. Springer, Berlin Heidelberg New York, pp 165–186
Bachmann B, Biscoping J, Sinnung E, Hempelmann G (1990) Protein binding of prilocaine in human plasma: influence of concentration, pH and temperature. Acta Anaesth Scand 34:311–314
Bakhle YS (1990) Pharmacokinetic and metabolic properties of lung. Br J Anaesth 65:79–93
Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA (1989) Lidocaine metabolism in human liver microsomes by cytochrome P450 IIIA4. Clin Pharmacol Ther 46:521–527
Ben-Harari RR, Joudim MBH (1983) The lung as an endocrine organ. Biochem Pharmacol 32:189–197
Bend JR, Serabjit-Singh CJ, Philpot RM (1985) The pulmonary uptake, accumulation, and metabolism of xenobiotics. Ann Rev Pharmacol Toxicol 25:97–125
Daniele RP (1990) Immunoglobulin secretion in the airways. Ann Rev Physiol 52:177–195
Foth H, Kietzmann D, Geng WP, Ebke M, Michaelis HC, Schröder T, Hering JP (1991) Pulmonary uptake of prilocaine, mepivacaine and bupivacaine. Naunyn-Schmiedeberg's Arch Pharmacol 343:R 5
Gibaldi M, Koup JR (1981) Pharmacokinetic concepts. Drug binding, apparent volume of distribution and clearance. Eur J Clin Pharmacol 20:299–305
Gibaldi M, Perrier D (1982) In: Gibaldi M, Perrier D (eds) Pharmacokinetics, 2nd edn. Marcel Dekker, New York, pp 45–50
Goehl TJ, Davenport JB, Stanley MJ (1973) Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey. Xenobiotica 3:761–772
Iwamoto K, Watanabe J, Aoyama Y (1988) Age-dependent pulmonary first-pass elimination of propranolol in rats. J Pharm Pharmacol 40:135–137
Jorfeld L, Lewis DH, Löfström JB, Post C (1983) Lung uptake of lidocaine in man as influenced by anaesthesia, mepivacaine infusion or lung insufficiency. Acta Anaesth Scand 27:4–9
Lewis CLP, Haschek WM, Cohen GM, Smith LL (1989) The accumulation of cystamine and its metabolism to taurine in rat lung slices. Biochem Pharmacol 38:481–488
Lüllmann H, Lüllmann-Rauch R, Wassermann O (1978) Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 27:1103–1108
McDevitt DG, Nies AS (1976) Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc Res 10:494–498
Michaelis HC, Geng WP, Foth H, Kahl GF (1990) Sensitive determination of bupivacaine in human plasma by high performance liquid chromatography. J Chromatogr 527:201–207
Minchin RF, Baraber HE, Ilett KF (1982) Effect of prolonged desmethylimipramine administration on the pulmonary clearance of 5-hydroxytryptamine and \-phenylethylamine in rats. Drug Metab Dispos 10:356–362
Oda Y, Imaoka S, Nakahira Y, Asada A, Fujimori M, Fujita S, Funae Y (1989) Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes. Biochem Pharmacol 24:4439–4444
Palazzo MGA, Kalso EA, Argiras E, Madgwick R, Sear JW (1991) First-pass lung uptake of bupivacaine: Effect of acidosis in an intact rabbit lung model. Br J Anaesth 67:759–763
Post C, Eriksdotter-Behm K (1982) Dependence of lung uptake of lidocaine in vivo on blood pH. Acta Pharmacol Toxicol 51:136–140
Roberts MS, Fraser S, Wagner A, McLeod J (1990) Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination. I. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate. J Pharmacokin Biopharm 18:209–234
Roerig DL, Kotrly KL, Vucins EJ, Ahlfs SB, Dawson CA, Kampine JP (1987) First-pass uptake of fentanyl, meperidine, and morphine in the human lung. Anesthesiology 69:466–472
Roerig DL, Kotrly KJ, Dawson CA, Ahlfs SB, Gualtieri JF, Kampine JP (1989) First-pass uptake of verapamil, diazepam, and thiopental in the human lung. Anesth Analg67:461–466
Ross BD (1972) Isolated perfused lung. In: Ross BD (ed) Perfusion techniques in biochemistry. A laboratory manual in the use of isolated perfused organs in biochemical experimentation. Clarendon Press, Oxford, pp 439–455
Rothstein P, Arthur GR, Feldman HS, Kopf GS, Covino BG (1986) Bupivacaine for intercostal nerve blocks in children: Blood concentrations and pharmacokinetics. Anesth Analg 65:625–632
Rothstein P, Cole JS, Pitt BR (1986) Pulmonary extraction of [3H]bupivacaine: modification by dose, propranolol and interaction with [14C]5-hydroxytryptamine. J Pharmacol Exp Ther 240:410–414
Tucker GT, Boas RA (1971) Pharmacokinetic aspects of intravenous regional anesthesia. Anesthesiology 34:538–549
Tucker GT, Mather LE (1988) Properties, absorption and disposition of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO (eds) Neural blockade in clinical anesthesia and management of pain, 2nd edn. JB Lippincott, Philadelphia, pp 47–110
Vetterlein F, Pethoe A, Schmidt G (1986) Distribution of capillary blood flow in rat kidney during postischemic renal failure. Am J Physiol 251:H510–519
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Foth, H., Geng, W.P., Krug, N. et al. Pulmonary uptake of bupivacaine in isolated perfused rat lung. Naunyn-Schmiedeberg's Arch Pharmacol 351, 99–106 (1995). https://doi.org/10.1007/BF00169070
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169070